BDBM477659 1-(1-(4-(Benzo[d][1,3]dioxolan-5-yl)-5-(ethoxymethyl)-4H-1,2,4-triazol-3-yl)azetidin-3-yl)-6-fluoro-1,2,3,4-tetrahydroquinoline 27::US10889569, Example 27

SMILES CCOCc1nnc(N2CC(C2)N2CCCc3cc(F)ccc23)n1-c1ccc2OCOc2c1

InChI Key InChIKey=VUBUPFNMUZWYDG-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 477659   

TargetVasopressin V2 receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477659(1-(1-(4-(Benzo[d][1,3]dioxolan-5-yl)-5-(ethoxymeth...)
Affinity DataIC50:  9.10E+3nMAssay Description:V2R: The inhibition effect of the compounds of the present invention on the activity of human V2R protein expressed in HEK293/human V2R cells was det...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477659(1-(1-(4-(Benzo[d][1,3]dioxolan-5-yl)-5-(ethoxymeth...)
Affinity DataIC50:  1.39E+4nMAssay Description:V1bR: The inhibition effect of the compounds of the present invention on the activity of human V1bR protein expressed in HEK293/human V1bR cells was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent